At the time the protocols were finalized, trial results for SURPASS-CVOT were not yet available
A Medical Providers Guide to the Mitochondrial Peptide for Metabolism, Energy, and Longevity MOTS-c is a 16-amino-acid peptide encoded in your mitochondrial DNA, and it has become one of the fastest-growing peptide therapies in metabolic and longevity medicine
Thankfully though our team at Essential Stacks have done the research for you
Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
Additionally, if youre in pursuit of an invigorating surge of energy and vitality, MIC B12 Lipo Shots present themselves as a viable option worth considering
Finally, with an understanding of cellular events subsequent to NAPQI, the rationale for potential therapies like fomepizole that may prevent or attenuate hepatocyte death long after NAPQI formation will be addressed
